Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Dokoupilova, Eva
NCT05405725: A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®	Recruiting	3	504	RoW	ENZ215, Prolia	Enzene Biosciences Ltd., Alkem Laboratories Ltd	Postmenopausal Osteoporosis	02/24	08/24
NCT05848258: An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis	Recruiting	2	380	Europe, US, RoW	LY3871801, Placebo	Eli Lilly and Company, Rigel Pharmaceuticals	Rheumatoid Arthritis	02/26	07/26